A Translational Research Program for the Development of New Strategies for Immunotherapy Against Cancer
Targeting of cancer neoantigens with donor-derived T cell receptor repertoires.
June 7, 2016 9:49 AM
Johanna Olweus and Ton N. Schumacher publish in Science in collaboration with Fridtjof Lund-Johansen.
Partnership to develop off-the-shelf NK cell therapy
Mar. 15, 2017 3:31 PM
Malmberg Lab enter into partnership with Fate Therapeutics Inc. to develop off-the-shelf NK cell therapy